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Abstract 
The primary cell surface receptor for SARS-CoV-2 is the angiotensin-converting 
enzyme 2 (ACE2). Recently it has been noticed that the viral Spike protein has an RGD 
motif, suggesting that cell surface integrins may be co-receptors. We examined the 
sequences of ACE2 and integrins with the Eukaryotic Linear Motif resource, ELM, and 
were presented with candidate short linear motifs (SLiMs) in their short, unstructured, 
cytosolic tails with potential roles in endocytosis, membrane dynamics, autophagy, 
cytoskeleton and cell signalling. These SLiM candidates are highly conserved in 
vertebrates. They suggest potential interactions with the AP2 µ2 subunit as well as I-BAR, 
LC3, PDZ, PTB and SH2 domains found in signalling and regulatory proteins present in 
epithelial lung cells. Several motifs overlap in the tail sequences, suggesting that they 
may act as molecular switches, often involving tyrosine phosphorylation status. Candidate 
LIR motifs are present in the tails of ACE2 and integrin β3, suggesting that these proteins 
can directly recruit autophagy components. We also noticed that the extracellular part of 
ACE2 has a conserved MIDAS structural motif, which are commonly used by β integrins 
for ligand binding, potentially supporting the proposal that integrins and ACE2 share 
common ligands. The findings presented here identify several molecular links and 
testable hypotheses that might help uncover the mechanisms of SARS-CoV-2 
attachment, entry and replication, and strengthen the possibility that it might be possible 
to develop host-directed therapies to dampen the efficiency of viral entry and hamper 
disease progression. The strong sequence conservation means that these putative SLiMs 
are good candidates: Nevertheless, SLiMs must always be validated by experimentation 
before they can be stated to be functional.  
Introduction 
The COVID-19 pandemic is caused by severe acute respiratory syndrome 
coronavirus 2 (SARS-CoV-2), an enveloped, single-stranded RNA virus. It had infected 
more than two and a half million people and caused circa 170,000 deaths globally by mid-
April 2020. SARS-CoV-2 belongs to the Coronaviridae family, whose members are 
common human pathogens responsible for the common cold, as well as for some 
emerging severe respiratory diseases. Among them are the SARS-CoV and the Middle 
East respiratory syndrome coronavirus (MERS-CoV), the former of which caused over 
8,000 cases in 2003 with a fatality rate of ~10%, and the latter caused about 2,500 
infections in 2012 with a fatality rate of 37% (de Wit et al., 2016). Another coronavirus, 
infectious bronchitis virus (IBV), infects birds and has been used as a model in 
coronavirus research (Sisk et al., 2018). SARS-CoV-2, like SARS-CoV (Li et al., 2003), 
uses the angiotensin converting enzyme 2 (ACE2) as a receptor to attach to the host cells 
(Hoffmann et al., 2020; Wrapp et al., 2020; P. Zhou et al., 2020). ACE2 is a single pass 
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type I membrane protein with a short cytosolic C-terminal region for which the 
functionality, however, is mostly unknown. 
Earlier results clearly show that the SARS-CoV-2 receptor binding domain (RBD) of 
the Spike protein interacts with ACE2 for cellular entry. However, type II alveolar cells 
(AT2) – the main targets of SARS-CoV-2 in the lung (Zou et al., 2020) – express a 
relatively low amount of ACE2, which points to the existence of co-receptors being 
targeted by the virus in parallel. One such candidate are integrins that bind a large variety 
of ligands harbouring an RGD sequence motif, as recent analysis of the RBD identified a 
possibly functional RGD motif (Sigrist et al., 2020). 
Integrins are major cell attachment receptors, which are known to be targeted by a 
range of viruses - including HIV, herpes simplex virus-2, Epstein-Barr virus (EBV) and the 
foot and mouth virus - for cell entry and activation of linked intracellular pathways (Hussein 
et al., 2015; Stewart and Nemerow, 2007; Triantafilou et al., 2001). Integrins are special 
types of receptors, as they propagate signals in both directions; extracellular ligands can 
induce cytoplasmic pathway activation, but intracellular binding on the cytosolic tails can 
influence the structure of the ectodomains and hence ligand-binding affinity. The 
complexity of integrin signalling stems in the dimeric structure of integrins, as they are 
composed of two subunits, α and β. For the RGD-binding integrins, the ligand binding 
surface lies at the interface of the two integrin subunits with both subunits making contacts 
with the ligand. These RGD motifs are recognized by at least 8 out of the 24 human 
integrins, and the flanking residues next to the core RGD motif are known to play a huge 
role in selectivity (Kapp et al., 2017). Several viral proteins contain RGD (or RGD-like) 
short linear motifs (SLiMs) for integrin modulation; and in addition, some viruses can not 
only use integrins on the host cell surface, but HIV and SIV can also incorporate integrins 
into their own membranes for mediating interactions with the host (Guzzo et al., 2017). 
Therefore, integrins can potentially be targeted at both the extracellular and the 
intracellular side to combat pathogenic hijacking. 
Viruses, as obligate intracellular entities, need to interfere with major cellular 
processes like vesicular trafficking, cell cycle, cellular transport, protein degradation or 
signal transduction to satisfy their replication, enzymatic, metabolic and transport needs 
(Davey et al., 2011). To achieve this, a large number of host processes are hijacked using 
SLiMs often located in intrinsically disordered regions to establish protein-protein 
interactions with host proteins or undergo post-translational modifications, like tyrosine 
phosphorylation. For example, cellular signalling relies heavily on the use of SLiMs (Van 
Roey et al., 2013, 2012). The low affinity and cooperativity of SLiM-based molecular 
processes allow reversible and transient interactions that can work as switches between 
distinct functional states and are regulated both in time and space (Gibson, 2009; Scott 
and Pawson, 2009). Conditional switching of SLiMs, for example through 
phosphorylation, can induce the exchange of binding partners for a protein, thus 
mediating molecular decision-making in response to signals reporting on the cell state 
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(Van Roey et al., 2012). The central resource for SLiMs is the Eukaryotic Linear Motif 
database (ELM; http://elm.eu.org/), also serving as an exploratory server for over 280 
manually curated SLiM classes with experimental evidence, each defined by a POSIX 
regular expression (Kumar et al., 2020). 
As explained above, a major strategy of viruses is to abuse the host system by using 
mimics of eukaryotic SLiMs to compete with extracellular or intracellular binding partners 
or to sequester host proteins (Davey et al., 2011). This dependence of viruses and many 
other pathogens on SLiM-mediated functions suggests that there is an opportunity to drug 
the cell systems where these interactions are being hijacked (Sámano-Sánchez and 
Gibson, 2020). For example, tyrosine kinase inhibitors, often used in anticancer therapy, 
have shown promising coronavirus replication inhibition in infectious cell culture systems 
(Coleman et al., 2016; Dong et al., 2020; Shin et al., 2018; Sisk et al., 2018). In the 
remainder of the introduction, we will describe some of the major pathways hijacked by 
viruses to accomplish cell attachment, entry and replication, which are suggested by our 
results to be relevant to SARS-CoV-2 infection. 
Receptor Mediated Endocytosis (RME) is a cellular import process triggered by cell 
surface receptor proteins, including any cargoes attached to them, in which a large 
vesicular structure is assembled entirely through cooperative low affinity interactions of 
SLiMs and phospholipid head groups with their globular protein domain partners. The 
vesicles are strong and stable, yet flexible and dynamically assembled and disassembled. 
The external triggering of surface receptors (many of which have the YxxPhi or NPxY 
tyrosine sorting motifs) is transmitted across the plasma membrane, inducing local 
enzymatic modification of lipid head-groups from PI4P to (PI(4,5)P2) by the PIPK1 kinase. 
The local enrichment of (PI(4,5)P2) enables binding of domains such as ENTH in Epsins 
which can begin to curve the membrane and assemble clathrin cages using their Clathrin 
Box motif and also attract additional adapter proteins via yet more SLiMs. In turn, 
additional sets of SLiM-bearing proteins stimulate the actin filament formation and 
attachment, necessary to fold and pull the invagination into the cytosol. Later, Dynamin 
binds directly to (PI(4,5)P2) on the membrane to complete the scission process. Once in 
the cytosol, the clathrin-coated vesicles are soon dismantled and the contents are 
included into the early endosomes. (For recent reviews of the process, see (Haucke and 
Kozlov, 2018; Kaksonen and Roux, 2018; Senju and Lappalainen, 2019). Many viruses 
enter the cell via endocytosis, using many different cell surface receptors (Grove and 
Marsh, 2011). Viruses such as HIV and Hepatitis C virus depend on the recognition of 
more than one receptor for entry, but in many cases the stoichiometry of receptor 
engagement is unknown. Coronaviruses can enter cells through different routes that 
include receptor mediated endocytosis or fusion at the membrane (de Haan and Rottier, 
2006). In the case of SARS-CoV, the main entry route is endocytic, and depends on 
endosome acidification (Huang et al., 2006; Simmons et al., 2004). However, protease-
mediated activation of the Spike protein relieves the pH-dependence of viral entry, 
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indicating that acidification is not a requirement per se, but acts by inducing the 
endosomal Spike protein cleavage required for viral fusion (Matsuyama et al., 2005; 
Simmons et al., 2005). Spike protein cleavage can be done by the transmembrane 
protease serine 2 (TMPRSS2) at the cell surface, or by Cathepsin L within endosomes 
(de Wilde et al., 2018). The same entry route and proteases are utilized by SARS-CoV-
2, and the main entry route also seems to be endocytic (Hoffmann et al., 2020; Ou et al., 
2020). 
Autophagy is an evolutionarily conserved process in eukaryotes with multiple cellular 
roles that include the regulation of cellular homeostasis through the catabolism of cell 
components, immune development and the host cell response to infection through 
pathogen phagocytosis (Deretic and Levine, 2009). Viruses have evolved mechanisms 
to block the host cell antiviral response, and can further hijack autophagy components to 
promote their survival and replication. This can be done through viral mimicry of host 
proteins coordinating autophagy or through the direct inhibition of the host autophagy 
machinery (Kudchodkar and Levine, 2009). Coronaviruses (CoVs) exploit the autophagy 
machinery through different mechanisms (Cong et al., 2017; Maier and Britton, 2012). 
For example, MERS-CoV targets the BECN1 autophagy regulator for degradation, 
blocking the fusion of autophagosomes and lysosomes and protecting the virus from 
degradation (Gassen et al., 2019). Coronaviruses repurpose cellular membranes to 
create double membrane vesicles (DMVs) onto which the replication-transcription 
complex (RTC) is assembled, a process that involves recruitment of multiple autophagy 
components (Cong et al., 2017; Prentice et al., 2004; V’kovski et al., 2019). 
Betacoronavirus mouse hepatitis virus (MHV) RTCs assemble by recruiting LC3-I, a non-
lipidated form of the LC3 autophagy protein (Cong et al., 2017; Reggiori et al., 2010), and 
SARS-CoV RTCs also colocalize with LC3 (Prentice et al., 2004). Proximity-based mass 
spectrometry on the MHV replication complex further revealed that the RTC environment 
repurposes components from the host autophagy, vesicular trafficking and translation 
machineries (V’kovski et al., 2019) 
In the present work, we identify a set of conserved SLiM candidates in the ACE2 and 
integrin proteins, which are likely to act in the cell entry system of SARS-CoV-2. These 
motifs can provide molecular links to understand how the virus recognizes target 
membranes, enters into cells, and how it repurposes intracellular membrane components 
to drive its replication. These molecular links might provide novel clues towards drugging 
SARS-CoV-2 infections. We first focus on the extracellular SLiMs, before moving across 
the membrane to examine the cytosolic potential of the receptor tails.  
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Extracellular receptor interplay and viral hijacking in the 
ACE2/integrin system 
Integrins are candidates for acting as co-receptors for SARS-CoV-2 entry 
The ability of SARS-CoV-2 RBD to bind integrins via the RGD motif (see Table 1) 
has not yet been assessed directly. However, there are several features that make the 
Spike-integrin interaction plausible, including sequence- and structure-level information, 
expression profiles, the presence of accessory motifs and protein-protein interactions. 
Evolution of the RGD motif in Spike receptor binding domain 
Aligning close homologues of the RBD from the Coronaviridae family (Figure 1A) 
shows that the motif candidate is located in a locally less conserved region, hinting at the 
rapid evolvability of the site. Several coronavirus RBDs contain KGD at this site, which is 
known to be a lower affinity integrin binding site, first identified in snake venom 
disintegrins, such as barbourin (Minoux et al., 2000). A KGD motif residing in the EBV 
gH/gL protein has also been shown to be essential for entry into epithelial and B cells 
(Chen et al., 2012). Figure 1B shows the tree derived from the Spike protein sequence 
alignment, highlighting that the SARS-CoV-2 RGD motif might have evolved from an 
earlier KGD motif, and might present a distinct step of adaptation if the motif is indeed an 
integrin attachment site. 
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Figure 1: The RGD motif of the SARS-CoV-2 spike protein. A) Multiple sequence alignment of 
a part of the SARS-CoV-2 Spike RBD region using 9 homologous sequences from closely related 
viruses and showing the conservation of the RGD motif. Red box marks the conservation range 
of the [RK]GD motif. Viruses' names, UniProt IDs and sequence numberings are listed on the left 
side of the alignment. The location of the region shown in the alignment is indicated in a 
representative diagram of the Spike protein. B) Guide neighbour joining tree of the multiple 
sequence alignment with the sequences containing the potential low- and high-affinity integrin 
binding motifs (KGD and RGD) shown in orange and red boxes, respectively. C) Structure of the 
SARS-CoV-2 RBD as seen in the ACE2-bound form (PDB ID:6m17). The RGD motif is shown in 
red sticks. Regions in direct contact with ACE2 are shown in blue. Residues with missing atomic 
coordinates (indicating flexibility) in the unbound trimeric Spike protein structures (PDB IDs: 6vsb, 
6vxx and 6vyb) are shown in transparency. Alignment and tree prepared in Jalview (Waterhouse 
et al., 2009) with Clustal colours. Structure was visualized using UCSF Chimera (Pettersen et al., 
2004). 
The RBD-integrin interaction is structurally feasible 
At the time of reporting the RGD motif, no SARS-CoV-2 Spike structures were 
available, so the authors used structural homology modelling to determine that the RGD 
motif is surface accessible (Sigrist et al., 2020). Since then, several RBD structures have 
been determined, both in unbound (Walls et al., 2020; Wrapp et al., 2020) and ACE2 
complexed forms using electron microscopy (Yan et al., 2020) and X-ray diffraction (Lan 
et al., 2020), allowing for the direct structural assessment of the possibility of binding to 
integrins. Figure 1C shows the RGD motif together with the residues involved in direct 
binding of ACE2. The RGD motif is located in the vicinity of the ACE2 binding site, 
however, based on uncomplexed structures of the RBD, the residues that surround the 
RGD site are flexible. This indicates that while ACE2 binding blocks the RGD motif, 
without ACE2 the RGD is surface accessible and interaction with integrins are not 
sterically blocked. 
As Spike exists as a trimer on the virion surface, different copies of the RBD can in 
theory interact with ACE2 and integrins at the same time. There is no solved complex 
structure of the ACE2-integrin complex. However, further structural consideration may 
indicate whether the Spike-ACE2 and the Spike-integrin interactions can coexist. The 
ectodomains of both ACE2 and integrins in the open conformation are roughly the same 
size measured from the membrane, being in the 150-200 Å range (based on available 
structures PDB:6m17 (Yan et al., 2020) and PDB:3ije (Xiong et al., 2009)). This means 
that the RGD-binding site of integrins and the RBD binding regions of ACE2 are relatively 
close in space. In addition, in the more open ‘up’ conformation of the RBDs, the distance 
between pairs of RBDs is about 100 Å (based on the structure PDB:6vsb reported in 
(Wrapp et al., 2020)), which is probably larger than the distance between the ACE2 
binding region and the integrin ligand binding site, estimated from the individual integrin 
and ACE2 structures. 
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α5β1 and αvβ3 integrins are potential targets for SARS-CoV-2 RBD 
The RGD motif is recognized by several integrins, and specificity is determined 
mostly by the flanking residues around the core motif. As evidenced by crystallized 
integrin dimer:ligand complexes, the residue preceding RGD is in contact with the α 
subunit, while the residue after the core motif interacts with the β subunit. The immediate 
context of the SARS-CoV-2 RBD motif is 402-IRGDE-406, which can give an indication 
about possible integrin targets. IRGD can be found in several native integrin-binding 
partners, including FREM1 (Kiyozumi et al., 2012), MFAP4 (Pilecki et al., 2015) and 
IGFBP1/2 (Cavaillé et al., 2006; Wang et al., 2006). These extracellular matrix proteins 
target integrins with αv, α5 and α8 subunits. RGDE is present in the native human integrin 
ligands TGF-β1, osteolectin, collagen α-1(VI) chain, PSBG-9 and polydom, and in vitro 
and in vivo binding studies on the specificity profiles of these proteins (Cescon et al., 
2015; Rattila et al., 2019; Sato-Nishiuchi et al., 2012; Shanley et al., 2013; Shen et al., 
2019; Tumbarello et al., 2012) highlighted a post-RGD Glu to be efficient in binding to β1, 
β2 and β3 integrin subunits. Correlating these preferences with possible α and β integrin 
subunit pairings points to the most likely candidate target integrins for SARS-CoV-2 being 
αvβ1, αvβ3, α5β1 and α8β1. 
Motif-domain interactions are typically under heavy spatio-temporal regulation. 
Hence the SARS-CoV-2 RBD-integrin binding can only occur if the possible target 
integrins are expressed on AT2 cells. Both α5β1 (Pilewski et al., 1997) and αvβ3 
(Caccavari et al., 2010; Nakamura et al., 2002; Singh et al., 2000) have been observed 
in lung epithelial cells and have been shown to be implicated in disease emergence and 
progression, including emphysema, non-small cell lung cancer and mechanical injury of 
the lungs (Teoh et al., 2015), marking these two integrins as prime suspects for targets 
of the RBD. 
Native ACE2/integrin interplay 
It has been shown that in heart tissues, ACE2 is able to bind the β1 subunit of 
integrins in an RGD-independent manner, enhancing cell adhesion and regulating integrin 
signalling via the focal adhesion kinase (FAK) (Clarke et al., 2012). The RGD 
independence of the interaction means that while ACE2 and integrins are in complex, the 
RGD binding site of the integrin is unoccupied, further supporting a potential 
integrin:ACE2:Spike ternary interaction. 
Apart from the known interplay between ACE2 and integrins, there are additional 
features that indicate an even tighter crosstalk between the two receptors. RGD-mediated 
binding to integrins is metal mediated (via divalent cations like Mg2+ or Mn2+), and all 
integrins have a so-called ‘metal ion-dependent adhesion site’ (MIDAS) motif (DxSxS) 
(Lee et al., 1995). The integrin MIDAS structural motif is located near the ligand binding 
site on the β subunit and is essential for binding, as sidechains belonging to the motif and 
an acidic residue from the ligand coordinate the metal ion together (Zhang and Chen, 
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2012). ACE2 also has a similar DxSxS motif (see Table 1), that might facilitate interactions 
with ligands that are recognized by integrins, possibly creating an overlap between the 
ligand binding profiles and regulation of the two receptors. In the known structures where 
Spike is bound to ACE2 the RGD motif is not in contact with the ACE2 MIDAS (Yan et 
al., 2020). However, the MIDAS motif is highly conserved across species (see Figure 2), 
and surface exposed. Consequently it may still be involved in mediating an interaction 
with an RGD-like motif, potentially serving as a parallel mechanism for binding the Spike 
protein. 
 
 
Figure 2: Alignment of ACE2 illustrating conservation of the MIDAS motif. Multiple sequence 
alignment of a part of the ACE2 extracellular region using 21 homologous sequences from 
different vertebrates (mammals, birds and reptiles) and showing the conservation of the Dx[ST]xS 
motif (main residues displayed above). Red boxes mark the conservation range of the MIDAS 
motif in all sequences. Organism names, UniProt IDs and sequence numberings are listed on the 
left side of the alignment. The location of the region shown in the alignment is indicated in a 
representative diagram of the ACE2 protein. Figure prepared with Jalview using Clustal colours.  
Protease usage by SARS-CoV-2 
ACE2 and several integrin subunits require proteolytic cleavage for biological activity 
(see Table 1). Integrin subunits α3, α5, α6 and αv are cleaved by furin or furin-like 
proprotein convertases (PCs) during maturation (Lehmann et al., 1996; Lissitzky et al., 
2000). Nearly all PCs contain an RGD motif, and while its role in integrin binding is not 
clear, the motif has been shown to be required for proper functioning for several PCs (Lou 
et al., 2007; Lusson et al., 1997; Rovère et al., 1999). The SARS-CoV-2 Spike protein 
contains a furin-like cleavage site that is absent from closely related Spike proteins, 
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immediately following the RBD (Coutard et al., 2020). This cleavage results in increased 
virulence, possibly by allowing greater movement of the RBD potentially aiding in 
exploring a larger space around the RBD-binding region of ACE2. 
ACE2 is cleaved by several proteases, including TMPRSS2 (Heurich et al., 2014). 
ACE2 binds to TMPRSS2, forming a receptor-protease complex (Shulla et al., 2011). 
TMPRSS2 is also known to cleave the Spike protein of both SARS-CoV and MERS-CoV 
(Iwata-Yoshikawa et al., 2019), augmenting their entry into the host cell (Heurich et al., 
2014). Furthermore, similar results have been found for SARS-CoV-2, where TMPRSS2 
was found to be fundamental for cell entry (Hoffmann et al., 2020). This dependence is 
most probably two-fold: on one hand TMPRSS2 is needed for ACE2 activation, on the 
other hand, SARS-CoV-2 Spike protein also contains a TMPRSS2 cleavage site (Meng 
et al., 2020). 
SLiM candidates in the ACE2 receptor intrinsically disordered 
tail 
The ACE2 sequence (UniProt:ACE2_HUMAN) was entered in the ELM server 
(Kumar et al., 2020) and returned several relevant candidate SLiMs in the short cytosolic 
C-terminal tail. Because SLiMs are so short, it is difficult to obtain significant results in 
sequence searches. Contextual information, including cell compartment localisation and 
functional relevance, is important in deciding whether a motif candidate is worth testing 
experimentally (Gibson et al., 2015). Furthermore, in intrinsically unstructured protein 
sequence, amino acid conservation is indicative of functional interactions. Therefore, an 
alignment was prepared of vertebrate ACE2 proteins. All of the detected motif matches 
(shown in Table 1 together with potential binding partner domains defined using Pfam (El-
Gebali et al., 2019) and InterPro (Mitchell et al., 2019)) were conserved in mammals, most 
were conserved with birds and mammals and some were conserved with extant reptiles 
(Figure 3). These groups diverged from one another >300 million years ago (Kemp, 2005) 
indicating a strong conservation of all candidate motifs. In addition, the functional contexts 
of these motifs are biologically coherent, involving signalling by tyrosine kinases, 
endocytosis, autophagy and actin filament induction (Table 1). In the following 
subsections we briefly summarise each of the conserved motifs and their possible role in 
the viral entry mechanism.  
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Figure 3: Alignment of ACE2 illustrating conserved motifs in the cytosolic C-terminal tail 
following the transmembrane helix. Multiple sequence alignment of ACE2 transmembrane and 
C-terminus regions using 21 homologous sequences from different vertebrates (mammals, birds 
and reptiles) and showing their motif conservation. The names (bold) and key residues of the 
motifs are displayed above the alignment (ɸ stands for a bulky hydrophobic residue), including a 
conserved tyrosine (bold) and excluded positions (red and crossed). Red boxes mark the 
conservation range of the PDZ-binding motif (PBM) (all sequences) and NPY motif (in mammals 
and birds). Organism names, UniProt IDs and sequence numberings are listed on the left side of 
the alignment. The location of the region shown in the alignment is indicated in a representative 
diagram of the ACE2 protein. Figure prepared with Jalview using Clustal colours.  
The YxxPhi endocytic sorting signal 
The YxxPhi motif binds the μ2 subunit (UniProt:AP2M1_HUMAN) of the endocytosis 
AP-2 adaptors by β-augmentation (Owen and Evans, 1998). It is found in numerous cell 
surface receptors which have intrinsically disordered C-terminal tails (Bonifacino and 
Traub, 2003). A small selection is listed in the database entry ELM:TRG_ENDOCYTIC_2, 
and while the motif has not been validated in ACE2, it is highly conserved (Figure 3). 
When the Tyr is phosphorylated, this motif becomes an SH2 binding site, while in the apo 
form it binds the μ2 adapter. Therefore, this motif can operate as a molecular switch. The 
residue following the Tyr makes a β-strand interaction and therefore cannot be a proline 
(PDB:1bxx). The Phi position requires a bulky hydrophobic residue. The motif pattern can 
be represented by the regular expression Y[^P].[LMVIF] and this motif is conserved in 
ACE2 from all mammals except monotremes. Thus the mammalian ACE2, which 
internalises the coronavirus, has a SLiM candidate for internalisation appropriately 
located within its cytosolic tail.  
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The NCK SH2 binding motif 
The region encompassing the YxxPhi motif overlaps with a Src homology 2 (SH2) 
domain binding motif (Figure 3) that is created upon phosphorylation of Tyr 781. SH2 
domain binding motifs are characterized by an invariant phosphotyrosine (pY) that is 
created following tyrosine kinase activation, and allows binding to more than 100 types of 
SH2 domains present in human proteins (Tinti et al., 2013). The pY residue is 
accompanied by additional binding determinants that frequently involve hydrophobic 
residues at the pY+3 position, but can also involve other combinations, such as Asn at 
pY+2 in Grb2-specific SH2 motifs, or hydrophobic residues at pY+4 in STAP-1 SH2 motifs 
(Huang et al., 2008; Kaneko et al., 2010). Most motifs are also characterized by the 
exclusion of residues at certain positions following the pY, and in general, SH2-binding 
motifs show a high degree of cross-specificity (Huang et al., 2008; Liu et al., 2010). 
Cell culture infection assays with different Coronaviruses, including SARS-CoV, have 
shown susceptibility to tyrosine kinase inhibitors, indicating the involvement of host 
tyrosine phosphorylation (Coleman et al., 2016; Dong et al., 2020; Shin et al., 2018; Sisk 
et al., 2018). The sequence found in ACE2 (781-YASID-785) best matches the binding 
specificity for the SH2 domain present in NCK1/2 proteins, which belong to the Class IA 
SH2 domains (Kaneko et al., 2010). Proteins known to contain this motif are listed in entry 
ELM:LIG_SH2_NCK1_1. NCK proteins are adaptor proteins that modulate actin 
cytoskeleton dynamics (Buday et al., 2002). For example, NCK is recruited to the cell 
membrane by the Nephrin protein, following tyrosine signalling that creates several NCK 
SH2 binding motifs in Nephrin (Blasutig et al., 2008). Once recruited to the membrane, 
NCK activates Wiskott-Aldrich syndrome (WASP) family proteins through the use of a 
helical binding motif (ELM:LIG_GBD_CHELIX_1) that relieves WASP autoinhibition and 
allows the recruitment of the actin regulatory protein complex Arp2/3, which leads to the 
initiation of actin polymerization (Okrut et al., 2015). The NCK binding motif is exploited 
by two known human pathogens, namely enteropathogenic Escherichia coli and vaccinia 
virus (Frese et al., 2006). The residues present at pY+1, pY+2 and pY+4 rule out that the 
ACE2 YASID motif can be a strong Grb2, CRK or STAP1 SH2 domain binder, and binding 
to STAT1/2/3 SH2 domains is also unlikely due to the lack of adequate specificity 
determinants. Other SH2 domains (e.g. Src-related) could be recruited by ACE2, and 
experimental validation will be required to test these hypotheses. 
The NPY IBAR binding motif 
Tyrosine 781 in ACE2 also overlaps a phosphorylation-independent NPY motif 
(ELM:LIG_IBAR_NPY_1). This motif was initially described in the bacterial secreted 
protein translocated intimin receptor (Tir) from pathogenic strains of E. coli like 
enterohaemorrhagic E. coli (EHEC). The NPY tripeptide recognizes and binds with a 60 
μM affinity to inverse Bin-Amphiphysin-Rvs (I-BAR) domains in adaptor proteins like 
insulin receptor substrate protein of 53 kDa (IRSp53) and its homolog insulin receptor 
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tyrosine kinase substrate (IRTKS) (Campellone et al., 2006; de Groot et al., 2011). I-BAR 
domains bind to the plasma membrane to favour weak membrane protrusions, and the 
preference of I-BAR domains for negative membrane curvatures enables a positive 
feedback loop that can result in the formation of lamellipodia, filopodia and other types of 
membrane protrusions (Chen et al., 2015; Prévost et al., 2015; Zhao et al., 2011). IRSp53 
and IRTKS are modular proteins that contain SH3 domains which in turn recognize PxxP 
SLiMs in actin filament regulators like Mena, Eps8 and mDia1 (Ahmed et al., 2010) 
resulting in the formation of membrane protrusions through actin filament formation 
(Campellone et al., 2006; Chen et al., 2015; Prévost et al., 2015; Zhao et al., 2011). 
Moreover, IRSp53 has an additional Cdc42-binding motif that can result in a direct WASP 
activation (Ahmed et al., 2010). During EHEC infection, the bacteria uses the NPY motif 
in the transmembrane protein Tir to recruit IRSp53 (Campellone et al., 2006). IRSp53 
acts as a scaffold to localize the injected bacterial protein EspFU to the bacterial 
attachment site, cytosolic side, through the binding of a PxxP motif in EspFU to the IRSp53 
SH3 domain. Through the use of the same helical SLiM present in NCK 
(ELM:LIG_GBD_CHELIX_1), EspFU acts as a potent WASP activator, inducing the actin 
polymerization that contributes to the pedestal formation characteristic of EHEC infections 
(Cheng et al., 2008; Sallee et al., 2008). The NPY SLiM, although not yet experimentally 
validated in any human protein, is potentially functional in proteins like SHANK2 or the 
microtubule-binding CLIP-associating protein 1 (CLASP1), based on protein conservation 
and functional association (de Groot et al., 2011). The putative NPY motif in ACE2 is 
conserved in all analysed mammalian and bird homologs (Figure 3), suggesting a direct 
interaction with host I-BAR-containing proteins such as IRSp53 or IRTKS, which are 
expressed in lung tissues (Uhlén et al., 2015). 
The I-BAR domain-binding motif in the cytosolic region of ACE2 could be relevant for 
SARS-CoV-2 infection in the following scenario. During viral cell entry, the NPY motif 
could recruit I-BAR-containing proteins such as IRSp53 or IRTKS, resulting in membrane 
protrusion formation that could be exploited for viral entry or in cell to cell transmission. It 
is known that the hijack of the filopodia formation network is beneficial for the entry and 
spreading of many enveloped viruses (reviewed in Chang et al., 2016), but whether this 
process is active during coronavirus infection is still unclear. A second route might 
cooperate with the NPY motif in the recruitment of actin cytoskeleton components. A 
direct interaction between the SARS-CoV Spike protein cytosolic side C-terminal domain 
and the Ezrin FERM domain can occur during the opening of the viral fusion pore and 
has been proposed to restrain viral infection (Millet et al., 2012). Ezrin is a protein involved 
in cell morphology and apical membrane remodelling that acts as a membrane-
cytoskeleton linker. Ezrin recruits F-actin through its C-terminal domain, and can also bind 
to IRSp53 located at negatively curved membranes (Saleh et al., 2009; Tsai et al., 2018), 
suggesting that while the NPY motif acts at earlier stages of viral attachment, the Spike 
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protein/Ezrin interaction might work during or after viral fusion, to promote the recruitment 
of actin regulatory components to viral fusion sites. 
The apoPTB domain-binding motif 
Certain members of the PTB domain family were discovered to bind to 
phosphorylated NPxY motifs, hence the designation Phospho-Tyrosine Binding domain 
(Zhou et al., 1995). The NPxY motifs in cytosolic tails of receptors, including integrins, are 
regarded as endocytosis sorting signals (Bonifacino and Traub, 2003). It was later 
discovered that PTB domains in the internalisation adapter protein Dab1 could also bind 
non-phosphorylated Nxx[FY] motifs (apoPTB motif) and that this might be the case for 
the majority of PTBs (Uhlik et al., 2005). Representative receptors with apoPTB motifs 
are in the database entry ELM:LIG_PTB_Apo_2. In ACE2, the core NxxF motif is 
conserved in all land vertebrates (Figure 3). For Dab1 apoPTB motifs, there is a 
hydrophobic requirement two residues before the Asn. In ACE2, this is predominantly a 
charged residue: Therefore, if this strikingly conserved NxxF is an apoPTB motif, it should 
bind a protein other than Dab1 and proteins with related specificities. The apoPTB motif 
binds as a short β-strand (β-augmentation) followed by a β-turn. Proline is rejected at one 
strand-forming position and therefore the regular expression for this motif would be 
[^P].N..F for land vertebrates or [EQ].N..F for mammals. As with the phosphorylated 
versions, the apo-motifs are tightly connected to endocytosis (Uhlik et al., 2005). 
The LC3-interacting region (LIR) autophagy motif 
Autophagy, the recycling of cellular material, is vital for cellular homeostasis. Many 
pathogens must control the autophagy response to establish productive infection (Deretic 
and Levine, 2009). It has been shown that coronaviruses, including human CoVs, subvert 
autophagy components to promote viral replication at DMVs associated to the RTC 
(Cottam et al., 2014; Fung and Liu, 2019; Gassen et al., 2019; Reggiori et al., 2010). The 
LIR motif is required for the interaction of a target protein with Atg8 or its homologues 
LC3 and GABARAP to facilitate autophagy of the target via the autophagosome 
(Birgisdottir et al., 2013). The LIR motif has been catalogued in the ELM resource entry 
ELM:LIG_LIR_Gen_1 which detected a candidate motif in the human ACE2 cytosolic tail 
sequence (Figure 3). After the LIR motif was annotated in ELM, a more recently solved 
LC3-LIR structure (PDB:5cx3) showed that the interacting peptide is longer, with one or 
two more hydrophobic interactions (Olsvik et al., 2015). LIR enters a hydrophobic groove 
bordered by positively charged residues. A core [WFY]xx[ILMV] enters the deepest part 
of the groove. On either side of the core, the interacting residues can be flexibly spaced. 
The core must be preceded by a negatively-charged residue (which might be enabled by 
phosphorylation). Further, the motif core is followed by a flexibly spaced hydrophobic 
residue. There is often a negatively-charged residue preceding this hydrophobic position: 
it can make favourable interactions with counter charges but is not an absolute 
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requirement, so is not included in the revised motif pattern. Based on the structure 
(PDB:5cx3) and some SPOT arrays (Alemu et al., 2012; Olsvik et al., 2015; Rasmussen 
et al., 2019), the regular expression [EDST].{0,2}[WFY][^RKP][^PG][ILMV].{0,4}[LIVFM] 
matches the motifs annotated in ELM. The revised motif is conserved in the mammalian 
ACE2 cytosolic tail, but not in birds or reptiles. The ACE2 LIR motif candidate can 
potentially enable the incoming coronavirus to attract autophagy elements such as LC3 
to the structures where the virus replicates and assembles. In line with this, a non-
lipidated form of the LC3 protein has been shown to be associated with the RTCs of MHV 
and SARS-CoV (Cong et al., 2017; Prentice et al., 2004; Reggiori et al., 2010). This brings 
up the interesting possibility that ACE2 remains associated with the membranous 
structures where SARS-CoV-2 replicates at later infection stages, assisting in the 
repurposing of autophagy components required for viral replication. 
The TxF$ PDZ-binding motif 
Amongst other motif-binding modules, PDZ domains come in great abundance in 
human and other multicellular animals (Ernst et al., 2009). PDZ domains take part in a 
variety of biological processes including cellular signalling and activity at the synapse 
(Manjunath et al., 2018). These domains bind SLiMs by β-strand augmentation which are 
called PDZ-binding motifs or PBMs, most commonly known to be found in the C-terminus 
of fully or partially disordered proteins. These interactions are widely studied and their link 
to various diseases and infections has been previously established (Christensen et al., 
2019). A PBM candidate is also found in the very C-terminus of the cytosolic tail of 
vertebrate ACE2 proteins (Figure 3). Motifs following a pattern [ST].[ACVILF]$ are a 
common PDZ-binding motif variant, described in the ELM resource entry 
ELM:LIG_PDZ_Class_1. There are multiple functional examples of this motif. However, 
in the ACE2 protein the matching sequence is not characterized. ACE2 has a disordered 
tail facing the cytosol, where a number of different PDZ domains could be its potential 
binders (Manjunath et al., 2018). 
Two PDZs in two different adapter proteins – Na(+)/H(+) exchange regulatory 
cofactor NHERF3 and SH3 and multiple ankyrin repeat domains protein 1 SHANK1 – 
have been previously identified to be able to bind TxF$ sequences (“$” stands for the C-
terminal end) (Ernst et al., 2014), which makes them both candidates for an interaction 
with the ACE2 C-terminus. NHERF3 is co-localised with ACE2 in intestinal tissue, and its 
PDZ domains were previously validated to interact with PBMs in transmembrane proteins 
on the cytosolic side of the membrane (Gisler et al., 2003), so it is possible they come in 
proximity with the ACE2 tail containing the TxF$ motif, and possibly bind it as a part of 
ion exchange regulation of small molecule transport activities. NHERF3 is known for its 
involvement in sodium ion-dependent transporter activity (Srivastava et al., 2019), and 
ACE2 was also shown to interact with a sodium-dependent transporter (Yan et al., 2020), 
which could be one of the leads towards unravelling the possible interaction between 
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NHERF3 and ACE2. NHERF3 (gene name PDZK1) and ACE2 share a network of 
experimentally validated protein-protein interactions localized at the cell membrane 
(Figure 4). These proteins share localisation and function characteristics, and some of 
them could turn out to be the missing puzzle pieces to connect ACE2 and NHERF3 as 
possible interactors. 
All in all, whether NHERF3 is the PDZ-containing protein interacting with ACE2 or not 
is an open question, but there should be very little doubt that ACE2 exhibits PDZ-binding 
activity in the cell, since the motif is highly conserved, very specific and already known to 
appear in membrane-associated proteins with C-terminal tails facing the cytosol. 
 
Figure 4: Experimentally validated interaction network between NHERF3 (PDZK1) and 
ACE2. C-terminal PBMs are displayed in white boxes. Common functionalities of the proteins 
marked by different colours. Thickness of nodes is proportional to the confidence behind the 
experimental evidence. The network was built using the STRING resource (https://string-db.org) 
(Szklarczyk et al., 2019). 
The phosphorylated Tyr781 in the ACE2 tail 
Tyrosine 781 is a part of the motif patterns for four of the motifs listed above but must 
be phosphorylated to act as an SH2-binding motif. Therefore, we searched the ACE2 
literature for reports of phosphorylation but were unable to find any with strong site 
identification. Examination of the human ACE2 entry in the database PhosphoSitePlus 
(Hornbeck et al., 2019) revealed that high-throughput (HTP) phosphoproteomic studies, 
but no low-throughput (LTP) studies, identify pTyr781. As shown in Figure 5, thirteen HTP 
measurements identified phosphorylation at Tyr781 and this residue is the only ACE2 
phosphosite that is highly reproducible across multiple HTP datasets. For example, 
pTyr781 was one of 318 unique phosphopeptides belonging to 215 proteins analysed 
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from an erlotinib-treated breast cancer cell line model (Tzouros et al., 2013). Therefore, 
this site indeed fulfils the phosphorylation requirement to be an SH2-binding motif. 
 
 
 
Figure 5: The summary for the ACE2 C-terminal tail provided by PhosphoSitePlus. No low-
throughput (LTP) studies have been recorded in the database for ACE2. Thirteen high-throughput 
(HTP) studies have identified pTyr781. Phosphosites reported in the extracellular part of ACE2 
have only been reported once each and therefore are likely to be misidentified peptides.  
A potential four way molecular switch at Tyr781 in the ACE2 tail 
As described above, four sequence motifs overlap in the region surrounding 
Tyr781: the YxxPhi endocytic sorting signal (ELM:TRG_ENDOCYTIC_2), an NCK SH2 
binding motif (ELM:LIG_SH2_NCK_1), an NPY I-BAR binding motif 
(ELM:LIG_IBAR_NPY_1) and the LIR autophagy motif (ELM:LIG_LIR_Gen_1). While the 
YxxPhi, NPY and LIR motifs require a non-phosphorylated state of Tyr781, the NCK motif 
requires Tyr781 phosphorylation, creating the opportunity for a four way molecular 
phospho-switch acting in this region of ACE2 that directs different steps of the SARS-
CoV-2 infection cycle. The state of this switch can be controlled by tyrosine kinase activity 
involving the Src/Abl and other tyrosine kinases known to be upregulated during 
endosomal processes (Reinecke and Caplan, 2014) and viral infection (Davey et al., 
2011) including in coronaviruses (Coleman et al., 2016; Dong et al., 2020; Shin et al., 
2018; Sisk et al., 2018). Similar two-way switches have been described before, as with 
the CTLA-4 receptors, where Src-family tyrosine kinases dictate the binding preferences 
of overlapping YxxPhi and SH2 binding motifs. In the non-phosphorylated state 
endocytosis is favoured, whereas T cell activation brings about Tyr phosphorylation, 
shutting down endosomal recycling and initiating signalling through the recruitment of 
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SH2-domain containing proteins (Bradshaw et al., 1997; Miyatake et al., 1998; Ohno et 
al., 1996; Owen and Evans, 1998; Shiratori et al., 1997). 
During early stages of viral infection, and following viral attachment to the host cell 
membrane, the YxxPhi motif could activate the early events of receptor-mediated 
endocytosis by binding the µ subunit of the AP2 complex, which in turn recruits clathrin 
and other endocytic components to the viral attachment sites. Following the formation of 
the clathrin coat and initial invagination, actin polymerization is required to assist in the 
internalization of the endocytic vesicles. In addition, some viruses can ‘surf’ along 
filopodia by myosin-mediated actin cytoskeleton movements that transport the viral 
particles to the entry sites at the cell body, ultimately increasing their entry rate (reviewed 
in Chang et al., 2016). The actin hijack related to endocytic uptake and the formation of 
membrane protrusions could be coordinated in one or several stages by the NCK SH2 
and NPY motifs respectively, by recruiting WASP and I-BAR proteins to the viral 
attachment site. This might be enacted by a Tyr781 phosphorylation switch that is 
regulated in time with early attachment characterized by non-phosphorylated Tyr781 that 
allows the YxxPhi and NPY motifs to be active, and a later phase where Tyr781 becomes 
phosphorylated, inactivating the YxxPhi and NPY motifs and bringing the NCK SH2 motif 
into play. An alternative scenario might be enabled by the multimeric nature of the Spike 
protein and by attachment of several viral particles to a membrane domain, leading to 
adjacent ACE2 tails on the intracellular side that expose both phosphorylated and non-
phosphorylated motifs, allowing these three signalling steps to take place simultaneously. 
The presence of several parallel routes for the recruitment of cytoskeleton components 
involving the NPY and NCK motifs could provide robustness needed to ensure the actin-
reorganization required for the uptake of virus-containing vesicles into the cytosol. 
Following endocytosis and fusion, viral components are released into the cell and viral 
replication takes place. During this phase, the last component of the switch could come 
into play, when the ACE2 protein that remains bound to Spike protein-coated membranes 
could promote the hijack of autophagy components necessary to assemble the viral 
replication factories. At this time, non-phosphorylated ACE2 tails would recruit LC3 to 
replication structures through their LIR motifs.  
Known and candidate motifs in the integrin β tails 
Integrin β tails are short cytosolic C-terminal intrinsically disordered regions, similar 
to the analysed region of ACE2. The two most probable integrin β subunit candidates at 
play in SARS-CoV-2 viral entry are β3 and β1. The C-terminal tail of both subunits share 
a high degree of sequence similarity, and similarly to ACE2, contain several known and 
candidate SLiMs (see Table 1 and Figure 6) that propagate signals in the cytoplasm and 
regulate integrin activity not just through intracellular pathways, but also changing the 
 18 
structural state of the ectodomains determining ligand binding capacity (Anthis and 
Campbell, 2011). 
The membrane proximal tyrosine kinase interacting region 
Integrin β tails contain a highly charged patch in their membrane proximal region. 
This region is indispensable for the interaction between integrins and tyrosine kinases, 
including the Src-family kinase Fyn (Reddy et al., 2008) and the focal adhesion kinase 
(FAK), most probably via the direct interaction with paxillin (Liu et al., 2002). Through 
these interactions, integrins regulate cytoskeletal remodelling (Lv et al., 2016) and the 
promotion of cell survival (Tang et al., 2007), as well as regulation of focal adhesion 
assembly and cell protrusion formation (Hu et al., 2014). In turn, FAK regulates integrin 
recycling and endosomal trafficking (Mana et al., 2020; Nader et al., 2016). 
Currently, there is no consensus sequence motif describing these interactions, 
although a definition of HDR[KR]E has been proposed (Legate and Fässler, 2009), fitting 
integrins β1, β3, β5 and β6. This motif is under heavy regulation by several mechanisms. 
First, the interaction with tyrosine kinases seem to involve additional residues N-terminal 
of the charged motif core – most notably the conserved lysine preceding the hydrophobic 
patch (Reddy et al., 1998) – that are only accessible in the active state of the integrin 
dimer, as these regions are buried in the membrane otherwise (Stefansson et al., 2004). 
Second, the D residue of the motif forms a salt bridge with the cytosolic tail of the α subunit 
of the integrin in the inactive conformation of the receptor. Thus, this motif region is 
dependent on integrin activation regulated by ligand binding and intracellular interactions 
mediated by the C-terminally located NPxY motifs. 
The NPxY motifs 
Both the β1 and β3 tails contain two regions that match the apoPTB motif defined in 
the ELM resource (ELM:LIG_PTB_Apo_2). Furthermore, these regions are known to 
have Tyr phosphorylation, matching the phosphorylated motif definition as well 
(ELM:LIG_PTB_Phospho_1). These regions are known to be able to form β-turns, and 
are recognition sites for phosphotyrosine-binding domains. NPxY motifs (or NxxY in the 
case of the second motif of the β3 tail) are the major sorting signals mediating interactions 
with FERM domains for regulating endosomal trafficking (Ghai et al., 2013). In integrin β 
tails these motifs recruit adaptor proteins and clathrin, serving as sorting signals (Ohno 
et al., 1995), and the NPxY motifs in the β1 tail have a direct connection to viral entry for 
reovirus (Maginnis et al., 2008). 
Interactions mediated by the NPxY motif switches 
The first NPxY motif binds talin-1, serving as a connection between the plasma 
membrane and the major cytoskeletal structures (Horwitz et al., 1986). Considering the 
expression profiles of talins, the most likely interaction partner of lung-expressed integrins 
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is talin-1. Talin-1 contains a FERM domain, similarly to Ezrin, which establishes a direct 
interaction with the SARS-CoV Spike protein upon viral fusion (Millet et al., 2012). 
However, the interaction between the RBD and integrins offers the virus an earlier point 
of interference with the cytoskeletal system, being able to modulate it cooperatively with 
the ACE2 actin-regulatory elements (NPY and NCK SH2 motifs) before and during 
cellular entry. The talin/integrin interaction however presents a feedback loop: the binding 
of talin on the cytoplasmic side induces a structural rearrangement on the ectodomains 
of integrins, enabling a higher affinity interaction with RGD motif containing ligands 
(Tadokoro et al., 2003).  
The first NPxY motif is also a binding site for Dok1, a negative regulator of integrin 
activation. Dok1 is in direct competition with talin for binding integrins (Tadokoro et al., 
2003). The competition is fundamentally influenced by phosphorylation on Tyr773 of the 
NPxY motif. The non-phosphorylated motif has a higher affinity towards talin, whereas 
phosphorylation prefers Dok1 (Oxley et al., 2008); thus Tyr773 acts as a phospho-switch 
that regulates integrin activation. 
The first NPxY motif also presents a site for a largely phosphorylation-independent 
interaction with the Integrin Cytoplasmic domain-Associated Protein-1 (ICAP-1). ICAP-1 
is a fundamental regulator of the assembly of focal adhesions (FA) and ICAP-1 
knockdown reduced FA assembly (Alvarez et al., 2008), possibly working in conjunction 
with the membrane-proximal charged motif. ICAP-1 seems to be specific for β1, and 
hence the therapeutic considerations for targeting this pathway requires the verification 
of the type of integrins expressed on AT2 cells (and other related cell types). 
The second NPxY motif is a binding site for kindlin (Ma et al., 2008). This interaction 
requires the integrin tail to be non-phosphorylated and phosphorylation on Tyr785 (for β3) 
can switch off the interaction with kindlin-2 (Bledzka et al., 2010). Kindlin binding (together 
with talin binding) is a crucial step in integrin activation, and hence regulates the 
availability of integrins for extracellular ligands (Herz et al., 2006), and was also 
suggested to play a role in TGF-β1 signalling (Kloeker et al., 2004). 
Building a complex switching mechanism from two phospho-switches 
The two NPxY(-like) motifs in the integrin β tails not only constitute two separate 
phospho-switches, but also act in synergy to give rise to more complex regulation. Filamin 
and the PTB domain region of Shc1 each bind to both NPxY motifs (Deshmukh et al., 
2010; Liu et al., 2015). Shc is an adaptor protein playing a key role in MAPK and Ras 
signalling pathways, and its interaction with integrin β3 requires both phosphorylations on 
Tyr773 and Tyr785 (Audero et al., 2004; Deshmukh et al., 2010). In contrast, binding of 
the Ig domain of filamin-A requires both tyrosines to be in a non-phosphorylated state. 
The filamin-A interaction can be considered as a main shutdown switch in integrin 
signalling, as this interaction induces the closed conformation of the integrin ectodomains, 
decreasing the chance of ligand binding (Liu et al., 2015). In addition, binding partners 
 20 
utilizing both NPxY motifs may also serve as stronger modulators of endosomal 
trafficking, switching on enhanced signals. 
Potential LIR autophagy motif in integrin β3 
The connection between autophagy and cell adhesion has already been described, 
showing that both reduced FAK signalling (Sandilands et al., 2011) and detachment from 
the extracellular matrix via integrins (Vlahakis and Debnath, 2017) enhances autophagy. 
Atg deficient cells have enhanced migration properties, and at the molecular level there 
seems to be a direct connection between Atg proteins and integrins as well: autophagy 
stimulation increases the co-localization of β1 integrin-containing vesicles with LC3-
stained autophagic vacuoles, while autophagy inhibition decreases the degradation of 
internalized β1 integrins (Tuloup-Minguez et al., 2013). In Drosophila cells it has been 
shown that the Wiskott-Aldrich syndrome protein and SCAR homolog (WASH) plays a 
connecting role between integrin recycling and the efficiency of phagocytic and 
autophagic clearance (Nagel et al., 2017). However, molecular details about how this 
connection is brought about are unclear. 
Sequence analysis of integrin β3 tails show a potential Atg-interacting LIR motif, 
similarly to the ACE2 tail. Low throughput phosphorylation assays have determined that 
both Tyr773 and Tyr785 (required for the functional PTB NPxY motif) are in fact 
phosphorylated in vivo. However, such assays have also determined additional 
phosphorylation sites in the β3 tail, Thr777, Ser778, Thr779 and Thr784. These 
phosphorylations aren't connected to the NPxY motif switches in any known way. 
However, the three phosphorylations between residues 777-779 and the following 
sequence region matches the LIR autophagy motif also found in the ACE2 tail. While the 
current motif definition does not exactly fit the β1 tail, there is also low throughput 
phosphorylation assay data (Wennerberg et al., 1998) for the existence of these 
phosphorylations in the corresponding residues, hinting at the possibility of the presence 
of a slightly modified motif. For both β1 and β3 tails, the phosphorylation provides the 
negative charge required N-terminal of the FxxIxY LIR motif hydrophobic core. 
Phosphopeptides spanning the candidate region should reveal whether the LIR motif-like 
region is a functional Atg-binding site in integrin β1, and also whether the multiple 
phosphorylations act as a rheostat, modulating the affinity of the interaction. The motif 
found in integrin β3 is also present in integrin β2, and the motif candidate identified in 
integrin β1 is also present in integrin β6. 
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Figure 6: Alignment of human integrins illustrating conserved motifs in the cytosolic C-
terminal tail. A) Multiple sequence alignment of human integrin C-terminus regions, not including 
the two divergent β tails (β4 and β8). The alignment shows their motif conservation of the NPxY 
and LIR motifs (key residues displayed above). Red boxes mark the conservation range of the 
PTB motif in all sequences and the location of the LIR motif in integrin β3. Protein names, UniProt 
IDs and sequence numberings are listed on the left side of the alignment. B-C) Summary of the 
PTMs on the integrin β1 and β3 C-terminal tails. Details of the experimental evidence for the PTB 
tyrosine phosphorylations are highlighted: pY783 & pY795 for β1 and pY773 & pY785 for β3. 
Graphs obtained from PhosphoSitePlus (09/04/2020). 
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Potential synergy between the ACE2 and integrin intracellular 
motifs 
Bringing together the candidate SLiMs identified in the integrin β and ACE2 tails 
potentially strengthens the functional links between them, and provides an emergent 
picture of SLiM-driven cooperative switches driving viral attachment, entry and replication 
(Figure 7). Following attachment of Spike to the receptors, the two NPxY motifs in the 
integrin β subunit could act cooperatively with the apoPTB and YxxPhi motifs in ACE2 as 
sorting signals that mediate the internalization of viral particles into endosomes. The 
presence of several endocytic motifs in close proximity would strengthen the interaction 
with the endocytosis apparatus creating a high-avidity environment for recruitment of 
RME components (Bonifacino and Traub, 2003). During this time, the phosphorylated 
integrin NPxY motifs would also reinforce viral attachment through inside out signalling, 
stabilizing the integrin ectodomain in the open, high affinity ligand-binding conformation. 
As discussed previously, RME also involves the recruitment of adaptor molecules that 
activate rearrangements of the actin cytoskeleton required for the internalization of the 
endocytic vesicle. At this stage, the NPY and NCK SH2 motifs in ACE2 would recruit 
several molecules that mediate actin polymerization signalling, prominently I-BAR 
containing proteins IRSp53 and IRTKS, and the WASP-Arp2/3 complex. While most of 
this actin signalling would serve to allow viral entry, additional actin recruitment processes 
could occur following viral fusion, such as that initiated by the interaction between the 
Spike protein and Ezrin. Finally, at later stages of infection, both integrins and ACE2 might 
remain attached to virus-associated DMVs and other replication-competent membranes 
where the RTC assembles. At this stage, ACE2 and integrins might cooperatively mediate 
the recruitment of autophagy components such as LC3, through the LIR motifs located in 
the cytosolic tails of both molecules.  
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Figure 7: Model of the proposed interplay between motifs in the interface between SARS-
CoV-2 and human AT2 cell to achieve receptor mediated endocytosis. Receptors of the 
SARS-CoV-2 (pink) and human AT2 cell (light blue), motifs involved in viral recognition and entry 
are shown in boxes. Elements shown in one of the monomers of a homotrimer (Spike) or 
homodimer (ACE2) are also present in the other proteins forming that complex. Lines below motif 
boxes represent each of the overlapping motifs in that specific region. Arrows indicate the related 
cellular process and the protein known to interact with their respective motif is indicated in 
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parenthesis. Phosphorylation sites are shown as red circles with the respective sequence position 
indicated. For the integrin β tail, the PTB/apoPTB phospho switch is depicted as two separate 
versions of the same motif region, and the subscripts represent the motif order in the sequence. 
The colour code is as follows: cleavage sites (brown), for motifs: apoPTB/PTB (orange), endocytic 
sorting signal (purple), I-BAR binding (red), LIR (blue), MIDAS (yellow), NCK (green), PBM 
(magenta), RGD (light red). SLiMs mediating interactions are marked with coloured aquares, 
protease cleavage sites are marked with hexagons, structural motifs are marked with ovals. Motifs 
marked with † are experimentally validated. 
Short linear motifs and their potential therapeutic implications 
The analysis of candidate SLiMs in ACE2 and integrins suggests that SARS-CoV-
2 hijacks both receptors, co-opting their SLiMs to drive viral attachment, entry and 
replication. This creates an opportunity for drugging these interactions, or the processes 
they control through Host Directed Therapies (HDTs), to prevent viral entry. A list of 
potentially useful drugs is presented in Table 2, together with ChEMBL accessions 
(Mendez et al., 2019). 
The sequence RGD is used by a large number of viruses for cell attachment, via 
integrins (Hussein et al., 2015). RGD mimics have been developed as inhibitors of 
integrin-extracellular matrix protein interaction for a variety of diseases. A cyclic RGD 
peptide (c-RGDfV, cilengitide) has been developed clinically for glioblastoma treatment 
and other cancers. It proved safe, but did not enhance the survival benefit (Stupp et al., 
2014). SARS-CoV-2 has a unique RGD sequence in the ACE2 binding region of its Spike 
protein. It has been speculated that integrins may have a potential role for infectivity 
(Sigrist et al., 2020). Therefore, integrin inhibitors like RGD mimetics might be able to 
block the RGD binding site(s) on target cells and block the attachment of the virus. 
Another application that has been suggested is bacterial sepsis (sepsis is also a dreaded 
complication in COVID-19 patients), and experimental evidence in animals is available 
(Garciarena et al., 2017). Cilengitide is relatively specific for integrin αvβ3 and also active 
on αvβ5, αvβ6. The antibody abituzumab (aka DI 17E6) is a pan-av antibody, i.e. also 
active against other αv integrins, and may consequently be better suited for blocking virus 
entry. It has been clinically tested in several cancer indications (Élez et al., 2015; Hussain 
et al., 2016). Cilengitide and abituzumab are made available for in vitro testing in the 
context of the SARS-CoV-2 pandemic by the company who developed it initially (contact: 
compound_donation@merckgroup.com). 
As discussed above, tyrosine kinase mediated phosphorylation plays an important 
role in virus entry and maturation, and several tyrosine kinase inhibitors have been 
developed in the clinic and show effects on viral infection. For example, saracatinib, a Src 
and Abl inhibitor which has completed several clinical trials, including some cancers, 
inhibited replication of different coronaviruses including MERS-CoV, SARS-CoV and 
HCoV-229E in cell culture infection experiments (Shin et al., 2018). After internalization 
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and endosomal trafficking, imatinib, an Abl inhibitor, prevented fusion of SARS-CoV and 
MERS-CoV virions at the endosomal membrane in infected cell culture experiments 
(Coleman et al., 2016). Using the avian model virus, IBV, imatinib and two other Abl 
inhibitors, GNF2 and GNF5, prevented the fusion of the Spike protein to the membrane 
of the target cell as well as cell-cell fusion and syncytia formation (Sisk et al., 2018). More 
recently, tyrphostin A9, a platelet-derived growth factor receptor (PDGFR) tyrosine kinase 
inhibitor came out from a high-throughput screening using cytopathic effect as readout, it 
also showed in vitro inhibitory capacity to transmissible gastroenteritis virus (TGEV), an 
alpha coronavirus that infects pigs (Dong et al., 2020). The authors also showed that 
tyrphostin A9 has a broad spectrum, being active against three other tested 
coronaviruses: MHV in L929 cells, porcine epidemic diarrhea virus in Vero cells and feline 
infectious peritonitis virus in CCL-94 cells. The mode of action was found to be through 
p38 MAPK, at the post-adsorption stage. As FAK has been implicated in viral entry for 
other viruses including influenza A (Elbahesh et al., 2014), experimental drugs targeting 
FAK, including some in clinical trials (de Jonge et al., 2019), can be considered for 
studying the potential Spike-induced integrin signalling. Currently, 39 tyrosine kinase 
inhibitors are approved by the FDA: eleven target non-receptor protein-tyrosine kinases 
and 28 inhibit receptor protein-tyrosine kinases (Roskoski, 2020). Consequently, tyrosine 
kinase inhibitors may be good candidates to test for their effect on SARS-CoV-2. 
A number of protease inhibitors are currently discussed for SARS-CoV-2 treatment. 
Serine protease inhibitor camostat mesylate is active against TMPRSS2 and blocks cell 
entry (Hoffmann et al., 2020). Only the Spike protein of SARS-CoV-2 contains a furin 
cleavage sequence (PRRARS|V). Consequently, furin convertase inhibitors are 
considered as antiviral agents (Shiryaev et al., 2007). 
Many viruses enter the cell via endocytosis, and a number of candidate SLiMs 
relevant for SARS-CoV-2 infection are related to endocytosis (see above). 
Chlorpromazine, an antipsychotic (via dopamine D2 antagonism) dating from the 1950s, 
is also a potent endocytosis inhibitor (which may explain some of its marked side effects, 
which can include low white blood cell levels). It promotes the assembly of adaptor 
proteins and clathrin on endosomal membranes thus depleting them from the plasma 
membrane, leading to a block in clathrin-mediated endocytosis (Wang et al., 1993). The 
potential use of endocytosis inhibitors such as Amiodarone (Stadler et al., 2008) and 
chlorpromazine in coronavirus infection is further discussed here (Yang and Shen, 2020). 
The situation with targeting autophagy seems unclear. Autophagy activators might 
help the cell to consume incoming virus - or speed up the establishment of the viral 
replication complexes and accelerate disease. Autophagy inhibitors might work in later 
stages of infection to dampen viral production, but this will depend on whether autophagy 
is active at the time or if the constituent components have been captured and effectively 
shut down. Several inhibitors/activators have been reported which can target autophagy 
and multiple auxiliary signals feeding into the process of autophagy (Table 2). One such 
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axis is via the mTORC1 complex. Active mTORC1 keeps the autophagy process inhibited 
by phosphorylating the ULK complex which is a key regulator in autophagy. Inhibition of 
mTORC1 activates autophagy. Multiple FDA approved mTOR inhibitors are known and 
include Rapamycin and Everolimus. Rapamycin has been shown to be effective in cell 
culture for countering MERS-CoV infection and might assist in tackling SARS-CoV-2 
infection (Kindrachuk et al., 2015) although the stage of infection might be crucial for the 
desired outcome. Simvastatin is another drug which is known to upregulate autophagy 
via the mTOR pathway (Wei et al., 2013). Simvastatin has also been reported to alleviate 
airway inflammation in a mouse asthma model (Gu et al., 2017). Another autophagy 
modulator is Niclosamide which regulates autophagy by targeting the autophagy regulator 
Beclin1 via SKP2 E3-ligase in MERS-CoV infection. In this case, reduced Beclin1 levels 
lead to blocking fusion of autophagosomes and lysosomes and hence the virus protects 
itself in the host (Gassen et al., 2019). Overall, inhibiting SKP2 by Niclosamide relieves 
Beclin1, allowing autophagosome-lysosome fusion and resumption of autophagy to 
reduce the MERS-CoV production. In addition, niclosamide valinomycin has been shown 
to target SARS-CoV in cell cultures as well (Wu et al., 2004). 
Discussion 
A recent proteomic study expressed 26 tagged SARS-CoV-2 proteins individually to 
create a viral-human protein-protein interaction map (Gordon et al., 2020). As a result, 69 
compounds, some being FDA approved, are candidates for drug repurposing. The Spike 
protein interacted with the GOLGA7-ZDHHC5 acyl-transferase complex, possibly for 
palmitoylation on Spike's cytosolic tail. Spike did not pull down ACE2 or any cell surface 
receptor protein, but these experiments are not an assay for viral entry, and therefore 
many protein interactions related to the viral entry mechanism are likely missing from 
these data. Therefore our observations of SLiM candidates in the viral attachment, entry 
and replication system reflect additional areas of the cell where drug repurposing for host-
directed therapy might be explored. Although tyrosine kinase inhibitors have frequently 
been shown to dampen pathogen invasion and disease progression in cell culture, there 
has been little effort to move these findings into the clinic (Sámano-Sánchez and Gibson, 
2020). Because of their widespread use in cancer, the safety profiles of tyrosine kinase 
inhibitors are well known and we wonder whether this might be a neglected opportunity. 
Drugging the cell to cure the pathogen using HDTs is unlikely to fully remove a virus. 
This would also be undesirable, because the immune system must mount a defence in 
order to prevent viral reinfection. Rather, dampening viral load during viral invasion or 
replication should be the target, to give the host defences time to respond. It is well known 
that drugs like Tamiflu that slows influenza exit, and therefore entry into uninfected cells, 
can only have a strong effect when taken prophylactically or early in infection (Bassetti et 
al., 2019). Depending on the importance of integrins in SARS-CoV-2 lung cell entry, 
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reducing viral entry is a possible role for cilengitide or other molecules that hamper 
integrin or ACE2 binding. An endocytosis inhibitor might play a similar role and is 
independent of receptor type. However, for any such inhibitor that passes the blood-brain 
barrier, effects on mood and other brain operations are an inevitable side effect: Even so, 
the endocytosis inhibitor chlorpromazine is a widely used drug with a well-known safety 
profile (Solmi et al., 2017).  
Due to the presence of the cell attachment motif RGD in SARS-CoV-2, integrin 
inhibitors seem worthwhile to explore further. Cilengitide, a relatively selective integrin 
αvβ3 and αvβ6 inhibitor (a cyclic peptide that proved safe in patients, but failed to show 
a survival benefit in glioblastoma (Stupp et al., 2014)) might be useful in two phases: it 
could block virus attachment to target cells, and it has also been proposed as a potential 
treatment in sepsis (Garciarena et al., 2017). Sepsis was the most frequently observed 
complication among COVID-19 patients in Wuhan (F. Zhou et al., 2020). Another potential 
application of integrin inhibitors, especially integrin αvβ6, would be lung fibrosis - patients 
on respirators tend to develop lung fibrosis, and show increased αvβ6 levels (Horan et 
al., 2008). The antibody abituzumab (aka DI 17E6) is a pan-αv antibody with high potency 
on αvβ6, i.e. also active against several αv integrins, and may consequently be better 
suited for blocking virus entry, or may be suitable for lung fibrosis or sepsis protection. It 
has been clinically tested in several cancer indications (Élez et al., 2015; Hussain et al., 
2016), and proved safe, but did not achieve a survival benefit in cancer. 
Whether the enzymatic function of ACE2 has a role in SARS-CoV-2 infection is 
unknown. However, it would be readily testable with available ACE2 inhibitors, like 
Captopril, on the market since the 1970s (Enalapril would not be suited for in vitro testing, 
as it needs to be activated in the liver to become the active ingredient). It might be 
productive to test for synergy between molecules that block viral binding to ACE2 and 
molecules that block binding to integrins.  
Summary/Conclusion 
We have presented evidence at the sequence level for SLiMs in ACE2 and β integrins 
with the potential to function in viral attachment, entry and replication for SARS-CoV-2. 
We identified several candidate molecular links and testable hypotheses that might help 
uncover the (still poorly understood) mechanisms of SARS-CoV-2 entry and replication. 
Because these motifs belong to host proteins acting as viral receptors, they are not 
revealed by virus-centred proteomic assays. Most of these putative motifs lack direct 
experimental evidence. That they may well be functional, however, is indicated by 
sequence conservation, in some cases for hundreds of millions of years. In addition, these 
motifs are in appropriate cellular contexts to interact with their respective partner proteins. 
Experimental validation will yield insights into receptor-mediated endocytosis for SARS-
CoV-2 virus and, in addition, for the role of ACE2 in the normal cell, where it surely has 
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much more functionality than being an angiotensin converting enzyme. Overall, the 
collection of candidate motifs in this system suggests that a range of host directed 
therapies might be explored including RGD inhibition, tyrosine kinase inhibition, 
endocytosis inhibition and autophagy inhibition and/or activation. 
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Table 2: Drugs acting on different processes involved in viral entry and infection. 
 
Name of Drug Mode of action  Clinical 
status 
Other details ChEMBL  
ID1 
Inhibitors of viral attachment 
Camostat Inhibits TMPRSS2 
Approved 
(Japan) 
Shown to be relevant in 
pancreatic fibrosis 
590799  
Abituzumab 
Integrin inhibition 
(αvβ6, pan-αv) 
Phase 2 in 
oncology 
May also be relevant in 
sepsis, fibrosis 
2109621  
Cilengitide 
Integrin inhibition 
(αvβ3, αvβ5, αvβ6) 
Phase 3 in 
oncology 
May also be relevant in 
sepsis, fibrosis 
429876  
Endocytosis inhibitors 
Amiodarone 
Inhibits late 
endosomes 
FDA Approved 
Cell culture based evidence 
for SARS-CoV2 
633  
Chlorpromazine 
Blocks Clathrin-
mediated 
endocytosis 
FDA Approved 
Anti-psychotic drug routinely 
used as endocytosis inhibitor 
in cell culture 
823  
Imatinib Abl inhibitor FDA Approved 
First line treatment for 
chronic myeloid leukaemia 
941  
Teicoplanin 
Inhibits Cathepsin L 
(late endosomes 
and lysosome) 
FDA Approved Glycopeptide antibiotic 2367892  
BI-853520 FAK inhibitor Phase 1 
FAK has been implicated in 
the Influenza A virus cell 
entry and replication3 
3544961  
Saracatinib Src and Abl inhibitor 
Phase 2 in 
oncology 
Currently also considered for 
Alzheimer's disease 
217092  
Tyrphostin A9 
PDGF receptor 
kinase inhibitor (plus 
other activities) 
Preclinical Inhibits actin ring formation 78150  
Autophagy modulators 
Azithromycin Not known FDA Approved 
Approved for multiple 
bacterial infections 
529  
Chloroquine 
Hydoxy-Chloroquine 
Lysosomal inhibition FDA Approved Antimalarial agent 
76 
1690 
Metformin 
NDUF modulation; 
mTOR pathway 
modulation (plus 
other activities?) 
FDA Approved Approved for type 2 diabetes 1431  
Rapamycin 
Everolimus 
mTORC1 inhibition FDA Approved 
To prevent transplant 
rejection 
1908360  
413  
Simvastatin 
Autophagy 
upregulation via 
mTOR 
FDA Approved 
Treatment for dyslipidemia 
and atherosclerosis 
prevention 
1064  
Niclosamide 
Valinomycin (VAL) 
Inhibits SKP2 
Niclosamide - 
FDA Approved;  
VAL - Preclinical 
Niclosamide - moderate 
effect; VAL targets SARS-
CoV in cell culture4 - known 
to inhibit SKP2 
1448  
NVP-
BEZ235/Dactolisib 
Autophagy induction Phase 2 PI3k/Akt/mTOR 1879463  
1Drug details are accessible by clicking ChEMBL ids (Mendez et al., 2019); 2(Stadler et al., 2008); 3(Elbahesh et al., 2014); 
4(Wu et al., 2004) 
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